ADC THERAPEUTICS SA

ADC Therapeutics Directors Grant 45K RSUs, Sell 12.6K Shares – A Tale of Confidence Amid Bearish Market .

Insider RSU grants and tax‑sales at ADC Therapeutics reveal board confidence in the antibody‑drug pipeline, while steady holdings signal no market panic.

ADC THERAPEUTICS SA
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

03/06/2026, 23:23

4 minutes to read

Redmile Group Sells 196,000 ADC Therapeutics Shares, Raising $75 Million in a Strategic Portfolio Shift

Redmile Group’s $75 million ADC Therapeutics sell‑off signals a confidence shift, reshaping investor outlook and offering a discounted entry amid pipeline uncertainty.

ADC THERAPEUTICS SA
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

03/04/2026, 03:16

4 minutes to read